About: Horizon Discovery

Facets (new session)
Description
Metadata
Settings
- Rule:
- Inverse Functional Properties:
- "Same As":

About: Horizon Discovery Goto Sponge NotDistinct Permalink

An Entity of Type : yago:WikicatResearchSupportCompanies, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)
QRcode icon

http://dbpedia.demo.openlinksw.com/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FHorizon_Discovery&invfp=IFP_OFF&sas=SAME_AS_OFF&graph=http%3A%2F%2Fdbpedia.org&graph=http%3A%2F%2Fdbpedia.org

Horizon Discovery Group plc (LSE: HZD) ("Horizon"), is a gene editing company that designs and engineers genetically modified cells and then applies them in research and clinical applications in human health. Horizon offers human disease models and reagents derived from genetically-engineered cells that its customers may use to gain knowledge of the genetic drivers of disease; develop novel drugs or cell therapies targeted at these genetic drivers; and develop companion diagnostics that predict patient response in the clinic.

Attributes	Values
rdf:type	Thing company schema:Organization dul:Agent dul:SocialPerson agent wikidata:Q24229398 Organization Business enterprise yago:WikicatBiotechnologyCompaniesOfTheUnitedKingdom yago:Abstraction100002137 yago:Company108058098 yago:Group100031264 yago:Institution108053576 yago:Organization108008335 yago:YagoLegalActor yago:YagoLegalActorGeo yago:YagoPermanentlyLocatedEntity organisation yago:SocialGroup107950920 yago:WikicatResearchSupportCompanies
rdfs:label	Horizon Discovery (en)
rdfs:comment	Horizon Discovery Group plc (LSE: HZD) ("Horizon"), is a gene editing company that designs and engineers genetically modified cells and then applies them in research and clinical applications in human health. Horizon offers human disease models and reagents derived from genetically-engineered cells that its customers may use to gain knowledge of the genetic drivers of disease; develop novel drugs or cell therapies targeted at these genetic drivers; and develop companion diagnostics that predict patient response in the clinic. (en)
foaf:name	Horizon Discovery Group plc (en)
name	Horizon Discovery Group plc (en)
foaf:depiction
dcterms:subject	2005 establishments in England Companies based in Cambridgeshire Science and technology in Cambridgeshire Research support companies South Cambridgeshire District Biotechnology companies of the United Kingdom Biotechnology companies established in 2005
Wikipage page ID	41602531 (xsd:integer)
Wikipage revision ID	1122562273 (xsd:integer)
Link from a Wikipage to another Wikipage	Cambridge Public limited company 2005 establishments in England PerkinElmer United Kingdom Genome editing Model organisms Chinese hamster ovary cell Companies based in Cambridgeshire HAP1 cells Science and technology in Cambridgeshire Isogenic human disease models Reporter gene Research support companies South Cambridgeshire District Biotechnology companies of the United Kingdom Bioproduction Biotechnology High-throughput screening Zinc finger nuclease Assay Biotechnology companies established in 2005 CRISPR Mammoth Biosciences Molecular reference standards Recombinant AAV mediated genome engineering
sameAs	Horizon Discovery Horizon Discovery Horizon Discovery Horizon Discovery
dbp:wikiPageUsesTemplate	dbt:Authority_control dbt:Infobox_company dbt:More_citations_needed dbt:Reflist dbt:Start_date dbt:Use_dmy_dates
thumbnail	wiki-commons:Special:FilePath/Horizon_Discovery_Company_Logo.png?width=300
area served	Worldwide (en)
founder	Prof. Alberto Bardelli, Dr. Chris Torrance (en)
industry	Biotechnology
key people	Terry Pizzie , Ian Gilham (en)
location city	Cambridge
location country	United Kingdom
locations	4 (xsd:integer)
logo	Horizon Discovery Company Logo.png (en)
logo size	210 (xsd:integer)
num employees	400 (xsd:integer)
products	Model organisms HAP1 cells Isogenic human disease models Reporter gene Molecular reference standards (en)
services	Bioproduction Assay (en) Custom cell line development using rAAV, ZFN and CRISPR (en) Combination High-throughput screening (en) Drug screening services (en) Target identification and validation (en)
type	Public limited company
has abstract	Horizon Discovery Group plc (LSE: HZD) ("Horizon"), is a gene editing company that designs and engineers genetically modified cells and then applies them in research and clinical applications in human health. Horizon offers human disease models and reagents derived from genetically-engineered cells that its customers may use to gain knowledge of the genetic drivers of disease; develop novel drugs or cell therapies targeted at these genetic drivers; and develop companion diagnostics that predict patient response in the clinic. Horizon is headquartered in Cambridge, UK, and is listed on the London Stock Exchange’s AIM market under the ticker “HZD”. Horizon signed agreements in December 2019 and January 2020 with Mammoth Biosciences to combine Mammoth's intellectual property in CRISPR with Horizon's expertise in Chinese hamster ovary cells. Perkin-Elmer acquired Horizon Discovery for $383 million (£296 million) in November 2020. (en)
gold:hypernym	Company
skos:closeMatch	http://www.grid.ac/institutes/grid.450827.c
prov:wasDerivedFrom	wikipedia-en:Horizon_Discovery?oldid=1122562273&ns=0

Faceted Search & Find service v1.17_git139 as of Feb 29 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 48 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software